Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00577 |
| Species: | Homo sapiens |
| Position : | chr9:5504029-5504679 |
| Year: | 2020 |
| Title: | GATA2 Regulates Constitutive PD-L1 and PD-L2 Expression in Brain Tumors |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | meningioma |
| PMID: | 32493985 |
| MONDO: | MONDO:0005149 |
| Tissue: | Brain |
| Tissue Ontology ID: | UBERON:0000955 |
| Cell Source: | KALS1 |
| CVCL ID: | |
| Cell Type: | meningioma cell |
| Cell Ontology ID: | CL:0000127 |
| Experiment Type: | Enhancer activity assay, TF binding assay, Functional perturbation assay |
| High Throughput Method: | ChIP-seq, RNA-seq |
| Low Throughput Method: | Luciferase Reporter Assay, RT-RT-qPCR, Flow Cytometry, shRNA Knockdown, Western blot |
| Target gene : | PDCD1LG2 |
| TF name : | GATA2 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| GATA2 | AP-1 transcription factor network | pid | 71 |
| GATA2 | Factors involved in megakaryocyte development and platelet production | reactome | 111 |
| GATA2 | HIF-1-alpha transcription factor network | pid | 67 |
| GATA2 | IL3 | netpath | 84 |
| GATA2 | Regulation of Androgen receptor activity | pid | 54 |
| GATA2 | Signaling events mediated by HDAC Class I | pid | 89 |
| GATA2 | Signaling events mediated by HDAC Class II | pid | 58 |
| GATA2 | Hs_Apoptosis_WP254_88977 | wikipathways | 31 |